182 related articles for article (PubMed ID: 1984486)
1. Tumoricidal activity of alveolar and peritoneal macrophages of C57BL/6 mice bearing metastatic or nonmetastatic variants of Lewis lung carcinoma.
Duffie GP; Young MR
J Leukoc Biol; 1991 Jan; 49(1):8-14. PubMed ID: 1984486
[TBL] [Abstract][Full Text] [Related]
2. Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants.
Young MR; Aquino S; Young ME
J Leukoc Biol; 1989 Mar; 45(3):262-73. PubMed ID: 2522492
[TBL] [Abstract][Full Text] [Related]
3. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
Young MR; Young ME; Wepsic HT
Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
[TBL] [Abstract][Full Text] [Related]
4. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
Young MR; Newby M
J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
[TBL] [Abstract][Full Text] [Related]
5. Suppressor alveolar macrophages in mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Endicott RA; Duffie GP; Wepsic HT
J Leukoc Biol; 1987 Dec; 42(6):682-8. PubMed ID: 3500255
[TBL] [Abstract][Full Text] [Related]
6. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma.
Young MR; Wheeler E; Newby M
J Natl Cancer Inst; 1986 Apr; 76(4):745-50. PubMed ID: 3457207
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
Young MR; Hoover CS
J Natl Cancer Inst; 1986 Aug; 77(2):425-9. PubMed ID: 2942724
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages.
Young MR; Newby M
Cancer Res; 1986 Jan; 46(1):160-4. PubMed ID: 3455665
[TBL] [Abstract][Full Text] [Related]
10. Enhancement in immunity of tumor bearing mice by immunization against prostaglandin E2.
Young MR; Henderson S
Immunol Commun; 1982; 11(5):345-56. PubMed ID: 6961100
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 does not inhibit tumoricidal activity of mouse macrophages against adherent tumor cells.
Utsugi T; Fidler IJ
J Immunol; 1991 Mar; 146(6):2066-71. PubMed ID: 2005391
[TBL] [Abstract][Full Text] [Related]
12. Maleic vinyl ether activation of murine macrophages against lung-metastasizing tumors.
Loveless SE; Munson AE
Cancer Res; 1981 Oct; 41(10):3901-6. PubMed ID: 7285000
[TBL] [Abstract][Full Text] [Related]
13. Effects of fish oil and corn oil diets on prostaglandin-dependent and myelopoiesis-associated immune suppressor mechanisms of mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Young ME
Cancer Res; 1989 Apr; 49(8):1931-6. PubMed ID: 2522813
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
Lala PK; Parhar RS; Singh P
Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621
[TBL] [Abstract][Full Text] [Related]
15. Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.
Young MR; Young ME; Kim K
Cancer Res; 1988 Dec; 48(23):6826-31. PubMed ID: 2972359
[TBL] [Abstract][Full Text] [Related]
16. Association of increased tumor cell responsiveness to prostaglandin E2 with more aggressive tumor behavior.
Young MR; Okada F; Tada M; Hosokawa M; Kobayashi H
Invasion Metastasis; 1991; 11(1):48-57. PubMed ID: 2061004
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
Parhar RS; Lala PK
J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated macrophages of mouse mammary tumors. I. Differential cytotoxicity of macrophages from metastatic and nonmetastatic tumors.
Loveless SE; Heppner GH
J Immunol; 1983 Oct; 131(4):2074-8. PubMed ID: 6619548
[TBL] [Abstract][Full Text] [Related]
19. Genetic immunotherapy by intrapleural, intraperitoneal and subcutaneous injection of IL-2 gene-modified Lewis lung carcinoma cells.
Heike Y; Takahashi M; Ohira T; Naruse I; Hama S; Ohe Y; Kasai T; Fukumoto H; Olsen KJ; Podack EE; Saijo N
Int J Cancer; 1997 Dec; 73(6):844-9. PubMed ID: 9399664
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of immune function and tumor growth inhibition by antibodies against prostaglandin E2.
Young MR; Dizer M
Immunol Commun; 1983; 12(1):11-23. PubMed ID: 6573300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
